Innovation Pharmaceuticals Inc (IPIX)

[PlentyParanoid]

Karin, you may be right. Last few PR:s (while being 'minor') have had the feel of responses to concerns raised by negotiation partner.
- IPIX has extended brilacidin patent protection with new 'method' patents.
- According to recent studies RT plus cisplatin every 3 weeks will stay the de facto standard of care in HNC.
- Stability of Brilacidin in simulated gastric environment shows that formulation of Brilacidin for oral treatment of IBD will not be a major obstacle.

At the very least IPIX seems to be addressing an audience beyond plain investors like us. As ffrol has often pointed out revelations like brilacidin is stable in gastric acid is nice to know but at this stage it will not move share price. However, it probably is important for a potential partner. Hopefully the effort will yield results.